Simplex Trading’s Ambrx Biopharma Inc AMAM Stock Holding History

Simplex Trading’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,600	Closed	-$193K	–	10264
2023 Q4	$193K	Sell	13,600 -189,400	-93%	-$2.15M	﹤0.01%	4724
2023 Q3	$2.33M	Buy	203,000 +190,300	+1,498%	+$2.59M	﹤0.01%	1939
2023 Q2	$209K	Buy	12,700 +6,700	+112%	+$84.2K	﹤0.01%	4253
2023 Q1	$53K	Buy	+6,000	New	+$30.2K	﹤0.01%	5864

Simplex Trading's AMAM Position: Q1 2024 in Review

Simplex Trading sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 7,657 shares — an estimated $109K sold.

Simplex Trading first reported a position in AMAM in Q4 2022 and held it in 5 quarters. The position peaked at $1.07M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Simplex Trading reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 7,657 Ambrx Biopharma Inc shares in Q1 2024, an estimated $109K.
Simplex Trading first reported a position in Ambrx Biopharma Inc in Q4 2022 and held it in 5 quarters.
Simplex Trading's Ambrx Biopharma Inc position peaked at $1.07M in Q1 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.